In LT patients exhibiting SF ≥365 μg/L and TFS <55%, an overall survival of 54.5% in comparison to 74.8% in the remaining group was observed and confirmed in the validation cohort (28.6% versus 72%). These data indicate that with TFS below 55% the elevation of SF is associated with a higher risk of post-LT mortality. Ferritin is also an acute phase protein elevated in response to immune-mediated and infectious stimuli, which may thus represent

a surrogate marker for a general predisposition for morbidity and mortality. In our NVP-AUY922 in vivo study, c-reactive protein levels were compared and found to be lower in the group in which SF correlated well with overall recipient survival (Table 4). Generally, elevated SF need not be linked to c-reactive protein levels in acute

phase responses.41, 42 In addition, advanced liver diseases can contribute to a low c-reactive protein level response by reduced hepatic protein synthesis. In patients treated with interferon alpha-2b decreased c-reactive protein and significant elevations of SF were reported.43 This indicates a differential activation of acute http://www.selleckchem.com/products/Y-27632.html phase markers such as c-reactive protein and SF, which is likely to be responsible for high SF, i.e., in adult-onset Still’s disease29, 30 and other conditions. In patients undergoing hemodialysis and those with metabolic syndrome, elevated SF without elevations of TFS44, 45 has been observed, and SF levels have been associated with inferior prognosis.19, 21 Therefore, SF and TFS are not only markers for iron overload but can indicate an activation of acute phase and possibly other mechanisms35, 36 that influence mortality. In our study cohorts, liver biopsy material was not available to correlate histological iron load with the biochemical data. However, an analysis of the National Health and Nutrition Examination Survey (NHANES) 1999-2002 reported that even modest

elevations of SF were associated with reduced cardiovascular fitness in young male subjects,46 and that SF may represent a morbidity-associated parameter. Against this background, the finding that elevated SF in addition to lower levels of TFS are predictive for mortality and morbidity may not indicate systemic iron overload. One limitation of this retrospective study is that no 上海皓元 measurements of iron metabolism parameters were performed or were available after LT, which should be studied in future analyses to observe whether elevated SF persists after LT in patients with decreased survival. In addition, it may be of interest to reanalyze the pretransplant situation in other studies17 to assess whether there is also a difference between patients with high or low TFS and elevated SF regarding mortality on the waiting list. This may contribute to potential pre-LT therapeutic strategies. In conclusion, we show that SF elevations before LT predict an increased mortality following LT. This risk is highest in patients with SF ≥365 μg/L and TFS <55%, which was identified as an independent parameter.